James Hambro & Partners LLP Has $105.78 Million Holdings in Intuitive Surgical, Inc. $ISRG

James Hambro & Partners LLP increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 236,545 shares of the medical equipment provider’s stock after purchasing an additional 2,898 shares during the period. Intuitive Surgical makes up 3.8% of James Hambro & Partners LLP’s investment portfolio, making the stock its 15th largest holding. James Hambro & Partners LLP owned about 0.07% of Intuitive Surgical worth $105,784,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in ISRG. Vanguard Group Inc. boosted its stake in Intuitive Surgical by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after purchasing an additional 670,302 shares during the last quarter. State Street Corp lifted its stake in Intuitive Surgical by 1.2% during the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider’s stock valued at $8,451,223,000 after acquiring an additional 182,871 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider’s stock worth $4,429,590,000 after acquiring an additional 109,904 shares during the last quarter. Norges Bank bought a new position in shares of Intuitive Surgical during the second quarter valued at about $2,569,260,000. Finally, Invesco Ltd. grew its holdings in shares of Intuitive Surgical by 4.8% in the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider’s stock valued at $2,402,488,000 after acquiring an additional 201,159 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently weighed in on ISRG. Citigroup lowered shares of Intuitive Surgical from a “buy” rating to a “neutral” rating and reduced their price target for the company from $650.00 to $635.00 in a research report on Thursday, December 11th. Piper Sandler increased their price objective on Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Royal Bank Of Canada raised their price target on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a report on Wednesday, December 17th. UBS Group set a $600.00 target price on Intuitive Surgical and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. Finally, Wells Fargo & Company raised their price target on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $611.08.

Intuitive Surgical Stock Performance

ISRG stock opened at $577.34 on Wednesday. The company has a market capitalization of $206.96 billion, a PE ratio of 76.37, a price-to-earnings-growth ratio of 5.33 and a beta of 1.68. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company’s 50 day moving average price is $547.18 and its two-hundred day moving average price is $505.91.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.84 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the completion of the sale, the executive vice president owned 3,056 shares of the company’s stock, valued at approximately $1,772,480. The trade was a 81.80% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the transaction, the chief executive officer owned 234,256 shares in the company, valued at approximately $128,266,872.80. The trade was a 9.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 114,007 shares of company stock valued at $63,533,844. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.